Annual D&A
$27.61M$20.88M-43.06%
Summary
- Current Value
- As of today, NVAX annual D&A is $27.61M, down -43.06% on
- Historical Performance
- NVAX annual D&A is down -4.96% over the past 3 years, up +465.26% over the past 5 years
- All-Time High Comparison
- NVAX annual D&A is currently -43.06% below its historical high of $48.50M set on
- 3-Year Low Comparison
- NVAX annual D&A is at its 3-year low
- Sector Comparison
- NVAX annual D&A is higher than 80.42% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| $27.61M | -43.1% | -5.0% | +465.3% | +1912.6% | ||
| $5.13M | -59.1% | -29.0% | +185.7% | – | ||
| $27.61M | -43.1% | -5.0% | +465.3% | – | ||
| Price | $10.08 | +26.2% | +68.8% | -95.5% | -80.8% | |
| $157.48M | -53.3% | -67.8% | +8.4% | +1357.5% | ||
| $683.18M | -21.4% | -74.1% | -23.6% | +1795.0% | ||
| $489.07M | -31.7% | -71.6% | +18.1% | +1170.5% | ||
| $1.12B | +64.7% | -43.3% | +136.2% | +10000.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $48.50M | -43.1% | |
| 5Y | $48.50M | -43.1% | |
| All | $48.50M | -43.1% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $27.61M | at low | |
| 5Y | $4.89M | N/A | +465.3% |
| All | $253.60K | >+9999.0% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of NVAX?
As of today, NVAX annual D&A is $27.61M
What is 1-year change in NVAX annual D&A?
NVAX annual D&A is down -43.06% year-over-year
What is 3-year change in NVAX annual D&A?
NVAX annual D&A is down -4.96% over the past 3 years
How far is NVAX annual D&A from its all-time high?
NVAX annual D&A is currently -43.06% below its historical high of $48.50M set on December 31, 2024
How does NVAX annual D&A rank versus sector peers?
NVAX annual D&A is higher than 80.42% of companies in Healthcare sector
When is NVAX next annual earnings release?
As of today, the next annual earnings release for NVAX has not been scheduled
Quarterly D&A
$5.13M$1.46M-22.17%
Summary
- Current Value
- As of today, NVAX quarterly D&A is $5.13M, down -22.17% on
- Historical Performance
- NVAX quarterly D&A is down -59.06% year-over-year, down -29.04% over the past 3 years
- All-Time High Comparison
- NVAX quarterly D&A is currently -59.65% below its historical high of $12.70M set on
- 3-Year Low Comparison
- NVAX quarterly D&A is at its 3-year low
- Sector Comparison
- NVAX quarterly D&A is higher than 75.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $5.13M | -22.2% | -59.1% | -29.0% | +185.7% | ||
| $27.61M | – | -43.1% | -5.0% | +465.3% | ||
| $27.61M | -21.1% | -43.1% | -5.0% | +465.3% | ||
| Price | $10.08 | +54.1% | +26.2% | +68.8% | -95.5% | |
| $34.12M | +7.8% | -56.4% | -78.9% | -44.4% | ||
| $129.61M | -52.5% | -23.5% | -76.0% | -71.7% | ||
| $100.92M | -22.4% | -37.5% | -75.9% | -44.8% | ||
| $147.14M | +108.9% | +66.6% | -58.8% | -47.4% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $12.52M | N/A | -59.1% |
| 3Y | $12.70M | -59.6% | |
| 5Y | $12.70M | -59.6% | |
| All | $12.70M | -59.6% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.13M | at low | |
| 3Y | $5.13M | at low | |
| 5Y | $1.79M | N/A | +185.7% |
| All | -$1.36M | +476.6% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of NVAX?
As of today, NVAX quarterly D&A is $5.13M
What is NVAX quarterly D&A most recent change?
NVAX quarterly D&A was down -22.17% on December 31, 2025
What is 1-year change in NVAX quarterly D&A?
NVAX quarterly D&A is down -59.06% year-over-year
How far is NVAX quarterly D&A from its all-time high?
NVAX quarterly D&A is currently -59.65% below its historical high of $12.70M set on September 30, 2024
How does NVAX quarterly D&A rank versus sector peers?
NVAX quarterly D&A is higher than 75.91% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
TTM D&A
$27.61M$7.39M-21.12%
Summary
- Current Value
- As of today, NVAX TTM D&A is $27.61M, down -21.12% on
- Historical Performance
- NVAX TTM D&A is down -43.06% year-over-year, down -4.96% over the past 3 years
- All-Time High Comparison
- NVAX TTM D&A is currently -43.06% below its historical high of $48.50M set on
- 3-Year Low Comparison
- NVAX TTM D&A is at its 3-year low
- Sector Comparison
- NVAX TTM D&A is higher than 79.45% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| $27.61M | -21.1% | -43.1% | -5.0% | +465.3% | ||
| $27.61M | – | -43.1% | -5.0% | +465.3% | ||
| $5.13M | -22.2% | -59.1% | -29.0% | +185.7% | ||
| Price | $10.08 | +54.1% | +26.2% | +68.8% | -95.5% | |
| -$18.03B | -9037.5% | -5446.3% | -3788.8% | -10000.0% | ||
| $1.12B | +5.5% | +64.7% | -43.3% | +136.2% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $48.50M | N/A | -43.1% |
| 3Y | $48.50M | -43.1% | |
| 5Y | $48.50M | -43.1% | |
| All | $48.50M | -43.1% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $27.61M | at low | |
| 3Y | $27.61M | at low | |
| 5Y | $4.89M | N/A | +465.3% |
| All | -$780.00K | +3640.1% |
TTM D&A History
FAQ
What is the current TTM D&A of NVAX?
As of today, NVAX TTM D&A is $27.61M
What is NVAX TTM D&A most recent change?
NVAX TTM D&A was down -21.12% on December 31, 2025
What is 1-year change in NVAX TTM D&A?
NVAX TTM D&A is down -43.06% year-over-year
How far is NVAX TTM D&A from its all-time high?
NVAX TTM D&A is currently -43.06% below its historical high of $48.50M set on December 31, 2024
How does NVAX TTM D&A rank versus sector peers?
NVAX TTM D&A is higher than 79.45% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069426000007/0001000694-26-000007-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069426000007/0001000694-26-000007-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax